Cover Story

  • Trends in 2017

    What will be the most dominant business trends in the pharmaceutical sector in the year ahead?

  • Increasing access to medicines via collaboration and digitisation

    A Vaidheesh, VP, South Asia and MD, India, GlaxoSmithKline Pharmaceuticals, in an exclusive interaction with Prathiba Raju mentions that in 2017 and beyond, the pharmaceutical...

  • Where the mind is without fear…

    TK Kanchana, Director-General, Organisation of Pharmaceutical Producers of India (OPPI) talks about the trends which are most likely to drive the industry’s fortunes and company...

  • A year of opportunities and challenges

    Vikas Bhadoria, Senior Partner, Mc Kinsey and Vivek Arora, Associate Partner, Mc Kinsey, talk about how the global industry is at the cusp of change...

  • Business trends in 2017

    Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare and National Head – Life Sciences practice, KPMG India, elaborates on the emerging trends, which...

  • Dominant business trends in 2017

    Ameesh Masurekar, Director, AIOCD Pharmasofttech AWACS, talks about the prevalence of online retail, therapeutic and regulatory measures to drive growth and stability in pharma sector

  • Indian pharma landscape in 2017

    Antal International takes a closer look at the business trends that could be game changers for India's growing pharmaceutical industry

  • Pharma cos need to realign biz models

    Pharma companies should focus on high-performing therapeutic area and geographic markets and they need to realign their business models to be able to cope up...

  • Fixed dose combination drugs – to be banned or not to be banned

    Ajay Bhargava, Vanita Bhargava and Aseem Chaturvedi explain how the FDC ban notification has adversely affected the pharma industry

  • Trends in global and Indian pharma industry

    Uttam Jain, Director, Neon Laboratories, elaborates on how the pharma industry will register positive growth trends in the next couple of years

  • Pharma cos brace up for a paradigm shift

    With vast and quick change in culture and various global platforms, the industry is to witness a growing trend of digitisation in the pharma industry....

  • Outlook for global medicines through 2021

    Growth in spending on medicines in major pharmerging markets has slowed from 2–10 percentage points over the past five years and is expected to slow...

  • Experts examine the strategies for a new VUCA WORLD

    Featuring – Jawed Zia, Novartis India – Mike Warmuth, Abbott – Daara Patel, IDMA – Dr Ajit Dangi, Danssen Consulting – Utkarsh Palnitkar, KPMG in India – Dr Arun...

  • Embracing change: Crucial to success in a VUCA world

    Jawed Zia, Country President, Novartis India, advises pharma leaders to constantly evaluate their skills and course correct to tackle the challenges in a VUCA world

  • India: The pulse of healthcare in emerging economies

    India was among the first countries in which Abbott expanded outside the US, way back in 1910. Today, more than 85 per cent of Abbott's...

  • The pharma industry worldwide is facing severe challenges that it has never faced before

    Titans of the pharma industry are adjusting their sails to adapt to an increasingly VUCA world where volatility, uncertainty, complexity and ambiguity are the only...

  • Navigating through turbulent waters

    Dr Ajit Dangi, President & CEO Danssen Consulting, shares his tips for pharma leaders to operate and thrive in a VUCA world which is beset...

  • Trends and challenges in a VUCA world

    Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare National Head – Life Sciences practice, KPMG India informs that the VUCA world has thrown...

  • Leadership strategy to SAVE clinical trials in India from VUCA

    Dr Arun Bhatt, Consultant – Clinical Research & Development, advocates the need for collective leadership which focusses on Skills, Attitude, Vision and Ethics (SAVE) to...

  • The GST GAMBIT

    As the deadline for GST roll out nears, the pharma industry is cautiously optimistic about its impact By Prathiba Raju

  • Raising Standards

    After a few falls starts and delays, India's pharmacopeia is finally being updated and harmonised with global norms. By Sachin Jagdale

  • A milestone in the making

    Pharma companies need to fine-tune their security policies and implement best practices to safeguard data integrity By Prathiba Raju

  • Telangana Pharma City An investors’ paradise

    Kalvakuntla Taraka Rama Rao (KTR), Minister of Industries and Commerce, IT and Urban Development, Government of Telangana, in an interaction with Prathiba Raju, elucidates on...

  • Back on Track

    After a lull, the Indian clinical trial industry is likely to witness progress, due to a slew of regulatory measures adopted by the government. However, a lot needs to...

  • Bolstering Data Integrity

    Pharma companies need to fine-tune their security policies and implement best practices to safeguard data integrity By Prathiba Raju

  • ‘Doctors are highly motivated to know about clinical insights from the pharma industry’

    DocPlexus, an online community for doctors, is building a bridge between pharma companies and doctors to improve clinical outcomes. Phanish Chandra, CEO, Docplexus, shares more...

  • Assurance and improvement in pharma IT through internal audits and assessments

    Sambit Mohapatra, Senior Associate Consultant, Infosys and Prasenjit Sen, Senior Consultant, Infosys, in this white paper provide a framework for effective utilisation of the second line of defense (integrated...